Bysanti is based on iloperidone, an active metabolite of a compound that forms the core of Fanapt, another drug by Vanda Pharmaceuticals.

Key opportunities in the bio-pharmaceutical logistics market include the expansion in personalized medicine distribution, ...

Key opportunities in the healthcare logistics market include the expansion of pharmaceutical distribution networks, rising ...

Vanda Pharmaceuticals is riding a regulatory roller coaster over the last few months. | Vanda Pharmaceuticals is riding a regulatory roller coaster over the last few months with two FDA approvals and ...

Almost £150bn has been wiped off Ozempic drugmaker Novo Nordisk after a trial of its new weight-loss drug fell short of expectations. Shares in the Danish pharmaceutical giant plunged by 15pc on ...

Unnatural Products, a biotech company founded by UC Santa Cruz alumni Cameron Pye (Ph.D. ’17, chemistry & biochemistry) and ...

Demand from patients for obesity medication is unrelenting. So, too, is the battle over who gets to develop and distribute ...

The market is estimated to ve valued at $226.24m in 2025. The global pharmaceutical robot market is projected at $471.44m by ...

The dental 3D printing market is witnessing substantial growth, with an estimated compound annual growth rate (CAGR) of ...

The first gene therapies approved to treat sickle cell disease in December 2023 are struggling on the market. But there are ...

Patients taking a standard dose of CagriSema lost 20.2% of their body weight after 84 weeks, compared with 23.6% for Lilly’s tirzepatide. “The trial did not achieve its primary endpoint of ...